We are live on ! Find out more
ATYR

aTyr Pharma
ATYR

50 hedge funds and large institutions have $143M invested in aTyr Pharma in 2015 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 20 increasing their positions, 12 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

67% more repeat investments, than reductions

Existing positions increased: 20 | Existing positions reduced: 12

0% more funds holding

Funds holding: 50 → 50 (0)

0% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 6

6% less capital invested

Capital invested by funds: $152M → $143M (-$9.08M)

50% less funds holding in top 10

Funds holding in top 10: 2 → 1 (-1)

Holders
50
Holders Change
–
Holders Change %
0%
% of All Funds
1.31%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.03%
New
6
Increased
20
Reduced
12
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BFA
BlackRock Fund Advisors
California
+$2.86M
2
Alyeska Investment Group
Alyeska Investment Group
Illinois
+$1.27M
3
RIM
RS Investment Management
California
+$1.26M
4
RSCM
Rock Springs Capital Management
Maryland
+$266K
5
TD Asset Management
TD Asset Management
Ontario, Canada
+$260K

Top Sellers

Rank Fund Capital Flow
1
DM
Deerfield Management
New York
-$4.74M
2
SFM
Sphera Funds Management
Israel
-$1.75M
3
MF
Magnetar Financial
Illinois
-$1.71M
4
Lord, Abbett & Co
Lord, Abbett & Co
New Jersey
-$694K
5
PI
Putnam Investments
Massachusetts
-$528K
Name Holding Trade Value Shares
Change 		Change in
Stake
ProShare Advisors
26
ProShare Advisors
Maryland
$196K +$202K +1,421 New
Citadel Advisors
27
Citadel Advisors
Florida
$195K +$202K +1,421 New
TCIM
28
TIAA CREF Investment Management
New York
$191K – – –
AIM
29
Alambic Investment Management
California
$190K +$196K +1,381 New
Charles Schwab
30
Charles Schwab
California
$179K +$5.41K +38 +3%
Millennium Management
31
Millennium Management
New York
$164K +$170K +1,192 New
D.E. Shaw & Co
32
D.E. Shaw & Co
New York
$145K +$150K +1,055 New
Goldman Sachs
33
Goldman Sachs
New York
$131K -$468K -3,292 -78%
NI
34
Numeric Investors
Massachusetts
$122K +$17.4K +122 +16%
California State Teachers Retirement System (CalSTRS)
35
California State Teachers Retirement System (CalSTRS)
California
$110K +$1.99K +14 +2%
TA
36
Teachers Advisors
New York
$87K – – –
New York State Common Retirement Fund
37
New York State Common Retirement Fund
New York
$54K – – –
Citigroup
38
Citigroup
New York
$51K +$51.8K +364 +7,280%
Morgan Stanley
39
Morgan Stanley
New York
$47K +$26.6K +187 +125%
PCM
40
Prelude Capital Management
New York
$46K +$44.1K +310 +1,476%
Bank of America
41
Bank of America
North Carolina
$39K +$40K +281 +28,100%
NFA
42
Nationwide Fund Advisors
Ohio
$38K – – –
AIG
43
American International Group
New York
$35K – – –
SO
44
STRS Ohio
Ohio
$18K – – –
BA
45
BlackRock Advisors
Delaware
$16K -$14.5K -102 -47%
BNP Paribas Financial Markets
46
BNP Paribas Financial Markets
France
$14.7K +$1.42K +10 +10%
Deutsche Bank
47
Deutsche Bank
Germany
$13K -$1.85K -13 -11%
Barclays
48
Barclays
United Kingdom
$4K +$4.41K +31 +1,550%
Manulife (Manufacturers Life Insurance)
49
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$8 – – –
DM
50
Deerfield Management
New York
– -$4.74M -32,966 Closed
1
2
3

ATYR Hedge Fund Activity: Q4 2015 in Review

50 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in aTyr Pharma (ATYR) for Q4 2015, worth a combined $143M — down 6% from $152M a quarter earlier.

Fund positioning in ATYR was balanced in Q4 2015: 6 funds opened new positions, 6 closed out, 20 added to existing stakes and 12 trimmed.

The largest buyer was BlackRock Fund Advisors, adding an estimated $2.86M. The largest seller was Deerfield Management, exiting entirely with an estimated $4.74M sold.

  • 50 institutional investors held aTyr Pharma (ATYR) as of Q4 2015, unchanged from Q3 2015.
  • Funds reported $143M of aTyr Pharma stock for Q4 2015, down 6% quarter-over-quarter.
  • 6 funds opened new aTyr Pharma positions in Q4 2015 and 6 closed out, a net change of 0 holders.
  • The largest aTyr Pharma buyer in Q4 2015 was BlackRock Fund Advisors, an estimated $2.86M added.
  • The largest aTyr Pharma seller in Q4 2015 was Deerfield Management, an estimated $4.74M sold.

Based on aggregated 13F filings for Q4 2015.